Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc. (MTNB) Revenue
Annual & quarterly revenue history · segment & region breakdown
MTNB · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsMatinas BioPharma Holdings, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Matinas BioPharma Holdings, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Matinas BioPharma Holdings, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Matinas BioPharma Holdings, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MTNB revenue · 4 questionsMTNB's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Matinas BioPharma Holdings, Inc. SEC filings · GAAP · Matinas BioPharma Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026